From Name

From Email

To Name

To Email

Message

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia

from News-Medical

UC study tests efficacy of immune regulating drug in treating patients with COVID-19 pneumonia News-Medical Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial. The research trial, called Sirolimus Treatment in Hospitalized Patients with COVID-19 Pneumonia (SCOPE), will examine the Food and Drug Administration-approved medication that is most commonly used to prevent organ rejection in patients with kidney transplants. It is also FDA-approved for the treatment of a rare lung disease, LAM. READ MORE

more